Scenario: You work for a large urban

Scenario: You work for a large urban medical center as a psychiatric/mental health nurse practitioner (PMHNP) as a member of the psychiatry department staff. Your medical center is associated with the local university, which has a medical school. Several times a year, you have third-year medical students rotating through psychiatry on your floor. One day, the chief of psychiatry calls you to her office. She informs you that the student’s instructor has been called out of town on a family emergency. The chief of psychiatry was planning to take a vacation for the rest of the week. She asks you to fill in the lecture that the instructor from the medical school was supposed to provide. She tells you, “they’re only third year, so it’s no big deal- they love to know about the biologic basis of illness and how it relates to diagnosis and treatment. I know you could do this!” She then tells you, “after you give them the lecture, you can let them go for the day.” Select one of the disorders you learned about this term Discuss the theoretical neurobiology underlying the condition Describe how the underlying neurobiology results in the symptoms observed in the disorder- specifically addressing (at the receptor level) the alterations in normal functioning. Provide the learner with an overview of medications that can be used to treat the condition- BE SURE to emphasize how the drug is believed to react with receptors/cells/neuronal units to treat disease symptoms Include a discussion of any controversies which exist in the treatment of this disorder (if none exist, be sure to emphasize this). State therapeutic endpoints, that is, if the condition is successfully treated, what can the person expect? List any laboratory studies/measures/assessment that should precede, be obtained during, or after the treatment and discuss the recommended frequencies for these studies/measures/assessments. Your work will be presented in the format of a PowerPoint presentation. You will include speaker notes (notes that give the reader of your slides a “pretty good idea” of what you would say about each slide). If you have never made speaker notes before, this article from Microsoft will be helpful: How to add speaker notes (Links to an external site.) You should also know that a casual “Youtube” video search will yield multiple videos showing you how to do this . In addition to your course text, you should supplement your work with at least three peer-reviewed publications that specifically address critical areas of this assignment. Rubric Week 10 Assignment Rubric Week 10 Assignment Rubric Criteria Ratings Pts 25 pts 25 pts 10 pts 10 pts 10 pts 10 pts 5 pts 5 pts Total Points: 100 This criterion is linked to a Learning Outcome Theoretical Neurobiology of Disorder 25 to >19.0 pts Accomplished Comprehensively discusses the theoretical neurobiological underpinnings of the disorder by first describing normal functioning and then how normal functioning is altered because of the condition. All areas outlined in course text and supplemental research reviewed should be addressed. 19 to >10.0 pts Proficient Discussion of the theoretical neurobiological basis of disorder not complete/incomplete with a gap of at least one major point (as defined by course text or from articles used to develop the assignment), or fails to provide a discussion of normal neurobiology or how normal neurobiology is believed to be impacted/altered resulted in manifestations of the disorder. 10 to >0 pts No Marks Multiple essential points missing ignores normal neurobiological functioning or fails to adequately describe two or more major points (as defined by course text or from articles used to develop the assignment) relevant to how normal neurobiology is believed to be impacted/altered resulting in manifestations of the disorder. This criterion is linked to a Learning Outcome Medications Used to Treat Condition 25 to >19.0 pts Accomplished Provides an overview of the medications which can be used to treat the disorder. Discussion should include: -First-line agents & theoretical mechanisms of action. -Second-line agents & theoretical mechanisms of action (if none, then this should be indicated). -Adjunctive medications/treatments and purported theoretical mechanisms of action (if none, then this should be indicated). NOTE: If information about an area of this evaluation parameter is unable to be obtained, the learner should make a statement indicating that no information is available specific to the area to avoid point loss. (20 points) 19 to >10.0 pts Proficient Provides an overview of the medications which can be used to treat the disorder. Discussion of this topic area omits only one of the following topics -First-line agents & theoretical mechanisms of action. -Second-line agents & theoretical mechanisms of action (if none, then this should be indicated). -Adjunctive medications/treatments and purported theoretical mechanisms of action (if none, then this should be indicated). NOTE: If information about an area of this evaluation parameter is unable to be obtained, the learner should make a statement indicating that no information is available specific to the area to avoid point loss. (15 points) 10 to >0 pts No Marks Provides an overview of the medications which can be used to treat the disorder. Discussion of this topic area omits more than one of the following topics -First-line agents & theoretical mechanisms of action. -Second-line agents & theoretical mechanisms of action (if none, then this should be indicated). -Adjunctive medications/treatments and purported theoretical mechanisms of action (if none, then this should be indicated). NOTE: If information about an area of this evaluation parameter is unable to be obtained, the learner should make a statement indicating that no information is available specific to the area to avoid point loss. (14-0 points) This criterion is linked to a Learning Outcome Selection of Best Medication for Condition 10 to >7.5 pts Accomplished Using the text and evidenced-based literature makes a “case” for the medication (or medication class) that has the most evidence for efficacy in treating the condition. The discussion should include the following parameters: -The preferred agent’s theoretical mechanism of action. -A detailed description of how the drug is believed to interact with receptors/cells/neuronal units. -Dosage ranges for the agent should be discussed -Special considerations for prescribing (e.g., renal disease, hepatic disease, etc.). NOTE: If information about an area of this evaluation parameter is unable to be obtained, the learner should make a statement indicating that no information is available specific to the area to avoid point loss. (10 points) 7.5 to >4.0 pts Proficient Using the text and evidenced-based literature makes a “case” for the medication (or medication class) that has the most evidence for efficacy in treating the condition. The discussion should include the following parameters with NO MORE than one missing parameter: -The preferred agent’s theoretical mechanism of action. -A detailed description of how the drug is believed to interact with receptors/cells/neuronal units. -Dosage ranges for the agent should be discussed -Special considerations for prescribing (e.g., renal disease, hepatic disease, etc.). NOTE: If information about an area of this evaluation parameter is unable to be obtained, the learner should make a statement indicating that no information is available specific to the area to avoid point loss. (7.5 -4 points) 4 to >0 pts No Marks Using the text and evidenced-based literature makes a “case” for the medication (or medication class) that has the most evidence for efficacy in treating the condition. The discussion should include the following parameters with NO MORE than two missing parameters: -The preferred agent’s theoretical mechanism of action. -A detailed description of how the drug is believed to interact with receptors/cells/neuronal units. -Dosage ranges for the agent should be discussed -Special considerations for prescribing (e.g., renal disease, hepatic disease, etc.). NOTE: If information about an area of this evaluation parameter is unable to be obtained, the learner should make a statement indicating that no information is available specific to the area to avoid point loss. (4-0) This criterion is linked to a Learning Outcome Controversies in Treatment 10 to >7.5 pts Accomplished Describe controversies in treatment objectively, outlining the nature of the debate and positions of each side of the debate in an objective manner. For example: -Debates over best agents to use -Debates over appropriate ways to dose/administer the agent -Debates over monitoring/evaluation of efficacy -Any other applicable debate -If no debates exist/are identified, the appropriate pertinent negatives are added to the narrative of the presentation. (10 point) 7.5 to >4.0 pts Proficient Partially describes controversies in treatment- for instance, states that controversy exists, but does not detail both sides of the debate in an objective manner. (7.5 -4 points) 4 to >0 pts No Marks Does not address controversies completely or addresses one side while excluding or demonstrating bias towards the other. (4-0) This criterion is linked to a Learning Outcome Therapeutic Endpoints 10 to >7.5 pts Accomplished Describes therapeutic endpoints with emphasis on: -Link between the psychopharmacologic agent and what the client could expect in terms of treatment/treatment efficacy -Timelines between initiation of medication and onset of action postulated time in which symptom improvement may be noted. -Discussion of what may occur with this agent, which would complicate treatment (for example, allergy, untoward side effect, intolerable side effects) and compelling “second choice” approaches to treatment and their therapeutic endpoints. (10 points) 7.5 to >4.0 pts Proficient Describes therapeutic endpoints with the omission of no more than ONE of the following parameters: -Link between the psychopharmacologic agent and what the client could expect in terms of treatment/treatment efficacy -Timelines between initiation of medication and onset of action postulated time in which symptom improvement may be noted. -Discussion of what may occur with this agent, which would complicate treatment (for example, allergy, untoward side effect, intolerable side effects) and compelling “second choice” approaches to treatment and their therapeutic endpoints. (7.5 -4 points) 4 to >0 pts No Marks Describes therapeutic endpoints with the omission of TWO or MORE of the following parameters: -Link between the psychopharmacologic agent and what the client could expect in terms of treatment/treatment efficacy -Timelines between initiation of medication and onset of action postulated time in which symptom improvement may be noted. -Discussion of what may occur with this agent, which would complicate treatment (for example, allergy, untoward side effect, intolerable side effects) and compelling “second choice” approaches to treatment and their therapeutic endpoints. (4-0) This criterion is linked to a Learning Outcome Laboratory Studies/Assessments of Importance 10 to >7.5 pts Accomplished Discussion of the following: -Laboratory studies that should be obtained prior to drug initiation -Diagnostic studies that should be obtained prior to drug initiation -Assessments that should be made prior to drug initiation -Ongoing laboratory/diagnostic studies/assessments which should be obtained during therapy INCLUDING duration at which the laboratory/diagnostic study or assessment should be obtained -Discussion of any of laboratory/ diagnostic study or assessment findings which would suggest the need to alter treatment. (10 points) 7.5 to >4.0 pts Proficient Discussion of the following with omission of NO MORE THAN ONE of the following parameters: -Laboratory studies that should be obtained prior to drug initiation -Diagnostic studies that should be obtained prior to drug initiation -Assessments that should be made prior to drug initiation -Ongoing laboratory/diagnostic studies/assessments which should be obtained during therapy INCLUDING duration at which the laboratory/diagnostic study or assessment should be obtained -Discussion of any of laboratory/ diagnostic study or assessment findings which would suggest the need to alter treatment. (7.5 -4 points) 4 to >0 pts No Marks Discussion of the following with omission of TWO OR MORE of the following parameters: -Laboratory studies that should be obtained prior to drug initiation -Diagnostic studies that should be obtained prior to drug initiation -Assessments that should be made prior to drug initiation -Ongoing laboratory/diagnostic studies/assessments which should be obtained during therapy INCLUDING duration at which the laboratory/diagnostic study or assessment should be obtained -Discussion of any of laboratory/ diagnostic study or assessment findings which would suggest the need to alter treatment. (4-0) This criterion is linked to a Learning Outcome Speaker Notes 5 to >3.75 pts Accomplished -Images are appropriate -Layout of images are pleasing to the eye -No spelling errors -No grammar errors -Text is in authors’ own words with minimal quotes (10 points) 3.75 to >2.0 pts Proficient Speaker notes adequate overall, with more than mild ambiguity (for instance, a major concept is introduced, but not explained). (7.5 -4 points) 2 to >0 pts No Marks Speaker notes either missing or generally lacking in their ability to convey what would be discussed/emphasized on the accompanying slide, AS INDICATED. (4-0) This criterion is linked to a Learning Outcome Appearance/Spelling/Grammar/Syntax 5 to >3.75 pts Accomplished -Images are appropriate -Layout of images are pleasing to the eye -No spelling errors -No grammar errors -Text is in authors’ own words with minimal quotes (5 points) 3.75 to >2.0 pts Proficient -Images appropriate overall -Layout is too “busy” with images/graphs overlapping texts. -Multiple quotes which could have been explained using authors own words -Presentation has 1-2 misspellings, but no grammatical errors (2.5 points) 2 to >0 pts No Marks -Images unattractive or sloppy on page obscuring parts of the text AND detract from the content of the presentation -Overuse of direct quotes from primary authors -Presentation has more than 2 grammatical and/or spelling errors (0 points) SCIENCE HEALTH SCIENCE NURSING NSG 5901

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."